Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus-Type 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05140876
What this trial is testing

Supporting Treatment Adherence for Resilience and Thriving (START)

Who this might be right for
Adherence, MedicationHIV-1-infectionStimulant Use
Florida International University 286
Early research (Phase 1)Study completedNCT02174159
What this trial is testing

Evaluation of Safety, Tolerability, Pharmacokinetics, and Antiretroviral Activity of Ulonivirine (MK-8507) in Human Immunodeficiency Virus (HIV-1)-Infected Participants (MK-8507-003)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 18
Testing effectiveness (Phase 2)Study completedNCT01097070
What this trial is testing

Assess the Pharmacokinetics of Bevirimat 100 mg Tablets Given to HIV-1 Positive Patient for 15 Days

Who this might be right for
HIV-1 Infection
Myrexis Inc. 35
Testing effectiveness (Phase 2)Study completedNCT01138605
What this trial is testing

TMC114-TiDP29-C232 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Children Coming From Any of the Three Ongoing Tibotec Sponsored Pediatric Studies With DRV

Who this might be right for
HIV-1 Infections
Janssen Sciences Ireland UC 46
Testing effectiveness (Phase 2)Ended earlyNCT00120783
What this trial is testing

Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 40
Post-approval studies (Phase 4)Study completedNCT00335270
What this trial is testing

A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination

Who this might be right for
HIV
Duke University 100
Large-scale testing (Phase 3)UnknownNCT05204394
What this trial is testing

Study to Evaluate Efficacy and Safety of Switching to VM-1500A-LAI + 2NRTIs From the 1st Line Standard of Care Therapy

Who this might be right for
HIV-1-infection
Viriom 438
Not applicableStudy completedNCT01109342
What this trial is testing

Extended Follow-Up of Participants in Preventive HIV Vaccine Studies in Uganda

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Post-approval studies (Phase 4)Study completedNCT00441688
What this trial is testing

Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 974
Testing effectiveness (Phase 2)Study completedNCT02651259
What this trial is testing

Evaluating PK, Tolerability, and Safety of Rifapentine and Isoniazid in Pregnant and Postpartum Women

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 50
Early research (Phase 1)Study completedNCT00000888
What this trial is testing

Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 14
Testing effectiveness (Phase 2)Study completedNCT01177059
What this trial is testing

Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 (HIV-1) Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical Trial

Who this might be right for
HIV-1
Janssen-Cilag Pty Ltd 68
Large-scale testing (Phase 3)Study completedNCT01095796
What this trial is testing

Study to Evaluate the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

Who this might be right for
HIVHIV Infections
Gilead Sciences 707
Very early researchStudy completedNCT04820933
What this trial is testing

Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV

Who this might be right for
HIV I InfectionCardiovascular Risk FactorLipid Metabolism Disorders
University of Texas Southwestern Medical Center 26
Large-scale testing (Phase 3)Active Not RecruitingNCT06333808
What this trial is testing

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy

Who this might be right for
HIV-1-infection
Gilead Sciences 577
Not applicableStudy completedNCT00001584
What this trial is testing

Determination of HIV-1 Production by the Prostate

Who this might be right for
HIV Infections
National Cancer Institute (NCI) 35
Not applicableStudy completedNCT01064752
What this trial is testing

A Pilot Study of the Effect of Minocycline on Cerebrospinal Fluid HIV-1 Infection

Who this might be right for
HIV Infection
University of California, San Francisco 7
Not applicableStudy completedNCT04675255
What this trial is testing

Assessing the Impact of INSTI to PI Switch on Insulin Sensitivity and Fat Metabolism

Who this might be right for
HIV I InfectionAdiposity
Washington University School of Medicine 8
Early research (Phase 1)Study completedNCT01140126
What this trial is testing

Study to Evaluate Safety and Pharmacokinetics of UB-421 Antibody in HIV-1 Infected Adults

Who this might be right for
HIV-1 Infection in Adults (Asymptomatic)
United Biomedical 20
Large-scale testing (Phase 3)Ended earlyNCT00147355
What this trial is testing

Toxicity Substudy of Evaluation of Subcutaneous Proleukin in a Randomised International Trial (ESPRIT): TOXIL-2 Substudy

Who this might be right for
HIV Infections
Kirby Institute 28
Next Page